reuterin has been researched along with Disease Models, Animal in 2 studies
*Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andren, A; Bell, HN; Das, NK; Fearon, ER; Goyert, J; Gygi, SP; Huang, W; Kerk, SA; Kuljanin, M; Lyssiotis, CA; Mancias, JD; Miller, SL; Rebernick, RJ; Shah, YM; Singhal, R; Solanki, S; Todd, PK | 1 |
| Algieri, F; Arqués, JL; Diez-Echave, P; Gálvez, J; García-Lafuente, A; Garrido-Mesa, J; Hidalgo-García, L; Landete, JM; Langa, S; Martín-Cabrejas, I; Mayer, MJ; Medina, M; Narbad, A; Rodríguez-Cabezas, ME; Rodríguez-Nogales, A; Vezza, T | 1 |
2 other study(ies) available for reuterin and Disease Models, Animal
| Article | Year |
|---|---|
Reuterin in the healthy gut microbiome suppresses colorectal cancer growth through altering redox balance.
Topics: Animals; Biomarkers; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Disease Models, Animal; Energy Metabolism; Gastrointestinal Microbiome; Glutathione; Glyceraldehyde; Host Microbial Interactions; Humans; Intestinal Mucosa; Metabolomics; Metagenomics; Mice; Models, Biological; Oxidation-Reduction; Oxidative Stress; Propane; Signal Transduction; Xenograft Model Antitumor Assays | 2022 |
Probiotic and Functional Properties of
Topics: Animals; Disease Models, Animal; Gastrointestinal Tract; Glyceraldehyde; Humans; In Vitro Techniques; Inflammation; Limosilactobacillus reuteri; Male; Mice; Mice, Inbred C57BL; Probiotics; Propane | 2021 |